THE USE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS BEYOND DISEASE PROGRESSION

被引：0
|
作者：
Papadopoulos, P. [1 ]
Brunetto, A. [1 ]
Ashley, S. [1 ]
Allen, M. [1 ]
Johnston, S. [1 ]
Smith, I. [1 ]
O'Brien, M. [1 ]
机构：
[1] Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [41] TRASTUZUMAB TREATMENT IN PATIENT WITH BREAST CANCER AND METASTATIC CNS DISEASE
    Perrucci, B.
    Montrone, M.
    Luccarelli, G.
    Lotesoriere, C.
    Nenna, C.
    D'Alessandro, A. R.
    Fanelli, F.
    Pisconti, S.
    [J]. CANCER TREATMENT REVIEWS, 2010, 36 : S102 - S102
  • [42] Clinical utility of continuing trastuzumab beyond brain progression in HER-2-positive metastatic breast cancer -: Reply
    Gori, Stefania
    De Angelis, Verena
    Colozza, Mariantonietta
    Crino, Lucio
    [J]. ONCOLOGIST, 2007, 12 (12): : 1469 - 1471
  • [43] SURVIVAL OF PATIENTS WITH HER2-POSITIVE ADVANCED BREAST CANCER (ABC) NOT CONTINUING TRASTUZUMAB (T) BEYOND DISEASE PROGRESSION AFTER DOCETAXEL (D) AND TRASTUZUMAB
    Montemurro, Filippo
    Faggiuolo, Roberto
    Donadio, Michela
    Redana, Stefania
    Minischetti, Monica
    Durando, Antonio
    Buosi, Roberta
    Vietti-Ramus, Guido
    Aglietta, Massimo
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 27 - 27
  • [44] HER2-positive breast cancer cells percentage and progression to trastuzumab treatment in metastatic patients
    Garcia-Garcia, Y.
    Martinez-Fernandez, A.
    Munoz Mateu, M.
    Fernandez-Ruiz, P.
    Garcia-Albeniz, X.
    Marmol-Casas, M.
    Domingo-Domenech, J.
    Pineda-Losada, E.
    Visa-Turmo, L.
    Gascon Vilaplana, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
    Perez, Jose
    Garrigos, Laia
    Gion, Maria
    Janne, Pasi A.
    Shitara, Kohei
    Siena, Salvatore
    Cortes, Javier
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 811 - 824
  • [46] ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS
    Rana, C.
    Mann, K.
    Wadhwa, A.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A158 - A158
  • [47] Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients
    Lunardi, G
    Vannozzi, MO
    Bighin, C
    Del Mastro, L
    Stevani, I
    Schettini, G
    Venturini, M
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (08) : 1222 - 1226
  • [48] Trastuzumab Beyond Disease Progression: Case Closed?
    Valabrega, Giorgio
    Aglietta, Massimo
    Montemurro, Filippo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : E121 - E122
  • [49] Continuation of trastuzumab beyond disease progression in patients with metastatic gastric cancer: A retrospective analysis of 25 cases-The MD Anderson experience.
    Al-Shamsi, Humaid Obaid
    Rogers, Jane
    Mares, Jeannette Elizabeth
    Blum, Mariela A.
    Dahbour, Ibrahim
    Fahmawi, Yazan
    Lin, Quan
    Ajani, Jaffer A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Subcutaneous trastuzumab in metastatic breast cancer
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (01)
12345